Keiji Nihei

Summary

Affiliation: National Cancer Center
Country: Japan

Publications

  1. ncbi Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan
    Keiji Nihei
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba 277 8577, Japan
    Jpn J Clin Oncol 35:745-52. 2005
  2. ncbi Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities
    Keiji Nihei
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Japan
    Int J Radiat Oncol Biol Phys 81:390-6. 2011
  3. ncbi Short-course palliative radiotherapy for airway stenosis in non-small cell lung cancer
    Keiji Nihei
    Division of Radiation Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa 277 8577, Japan
    Int J Clin Oncol 7:284-8. 2002
  4. ncbi High-dose proton beam therapy for Stage I non-small-cell lung cancer
    Keiji Nihei
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Radiat Oncol Biol Phys 65:107-11. 2006
  5. ncbi Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer
    Yoichi Naito
    Thoracic Oncology Division, National Cancer Center Hospital East, Kashiwa, Japan
    J Thorac Oncol 3:617-22. 2008
  6. ncbi A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG)
    Koichi Isobe
    Department of Radiology, Chiba University Hospital, Chiba, Japan
    Int J Radiat Oncol Biol Phys 69:1181-6. 2007
  7. ncbi Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion
    Seiji Niho
    Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 3:723-7. 2008
  8. ncbi Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis
    Seiji Niho
    Division of Thoracic Oncology and Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan
    J Thorac Oncol 6:796-800. 2011
  9. ncbi Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia
    Eiji Ikeda
    Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Jpn J Clin Oncol 41:964-72. 2011
  10. ncbi A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer
    Satoshi Takeuchi
    Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
    Am J Clin Oncol 30:607-11. 2007

Detail Information

Publications26

  1. ncbi Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan
    Keiji Nihei
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba 277 8577, Japan
    Jpn J Clin Oncol 35:745-52. 2005
    ..To assess the feasibility of high-dose radiotherapy for prostate cancer using proton boost therapy following photon radiotherapy...
  2. ncbi Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities
    Keiji Nihei
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Japan
    Int J Radiat Oncol Biol Phys 81:390-6. 2011
    ..The purpose of the present study was to estimate prospectively the incidence of late rectal toxicities after PBT for organ-confined prostate cancer...
  3. ncbi Short-course palliative radiotherapy for airway stenosis in non-small cell lung cancer
    Keiji Nihei
    Division of Radiation Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa 277 8577, Japan
    Int J Clin Oncol 7:284-8. 2002
    ..We investigated, retrospectively, the outcome of short-course palliative radiotherapy for airway stenosis in non-small cell lung cancer...
  4. ncbi High-dose proton beam therapy for Stage I non-small-cell lung cancer
    Keiji Nihei
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Radiat Oncol Biol Phys 65:107-11. 2006
    ..To evaluate retrospectively the safety and efficacy of high-dose proton beam therapy (PBT) for Stage I non-small-cell lung cancer (NSCLC)...
  5. ncbi Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer
    Yoichi Naito
    Thoracic Oncology Division, National Cancer Center Hospital East, Kashiwa, Japan
    J Thorac Oncol 3:617-22. 2008
    ....
  6. ncbi A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG)
    Koichi Isobe
    Department of Radiology, Chiba University Hospital, Chiba, Japan
    Int J Radiat Oncol Biol Phys 69:1181-6. 2007
    ..The aim of this study was to evaluate the efficacy and toxicity of moderate dose radiation therapy (RT) for mucosa-associated lymphoid tissue (MALT) lymphoma in a prospective multicenter phase II trial...
  7. ncbi Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion
    Seiji Niho
    Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Thorac Oncol 3:723-7. 2008
    ..We retrospectively investigated the clinical outcome of LD-SCLC patients with ipsilateral pleural effusion...
  8. ncbi Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis
    Seiji Niho
    Division of Thoracic Oncology and Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan
    J Thorac Oncol 6:796-800. 2011
    ..The clinical course of small cell lung cancer (SCLC) with pericardial effusion but without distant metastasis (M1a) has not been adequately investigated...
  9. ncbi Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia
    Eiji Ikeda
    Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Jpn J Clin Oncol 41:964-72. 2011
    ..To retrospectively assess the efficacy and safety of palliative chemoradiotherapy in Stage IVB esophageal cancer patients with dysphagia due to the primary lesion...
  10. ncbi A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer
    Satoshi Takeuchi
    Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
    Am J Clin Oncol 30:607-11. 2007
    ..We conducted a retrospective comparison of the outcomes of CRT between elderly and nonelderly patients with Stage II-III (non-T4) esophageal cancer...
  11. ncbi Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus
    Masakatsu Onozawa
    Radiation Oncology Division, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba, Japan
    Radiother Oncol 92:266-9. 2009
    ..The purpose of the present study is to retrospectively evaluate the efficacy of elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for thoracic esophageal cancer...
  12. ncbi Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus
    Satoshi Ishikura
    Radiation Oncology Division, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa 277 8577, Japan
    J Clin Oncol 21:2697-702. 2003
    ..To assess the long-term toxicity after definitive chemoradiotherapy (CRT) for squamous cell carcinoma (SCC) of the esophagus...
  13. ncbi Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study
    Sadamoto Zenda
    Division of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Radiat Oncol Biol Phys 81:135-9. 2011
    ..The aim of this pilot study was to assess the clinical benefit of proton beam therapy for mucosal melanoma of the head and neck...
  14. ncbi A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC)
    Satoshi Ishikura
    Division of Radiation Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwa noha, Kashiwa 277 8577, Japan
    Int J Radiat Oncol Biol Phys 61:1117-22. 2005
    ..The purpose was to assess the feasibility and efficacy of hyperfractionated accelerated radiotherapy (HART) after induction chemotherapy for Stage III non-small-cell lung cancer...
  15. ncbi Efficacy of chemoradiotherapy on pain relief in patients with intrapelvic recurrence of rectal cancer
    Yoshinori Ito
    Division of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Jpn J Clin Oncol 33:180-5. 2003
    ..To assess the efficacy of chemoradiotherapy on pain relief in patients with intrapelvic recurrence of rectal cancer...
  16. ncbi Proton-beam therapy for olfactory neuroblastoma
    Hideki Nishimura
    Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Radiat Oncol Biol Phys 68:758-62. 2007
    ..Proton-beam therapy can provide better dose distribution compared with X-ray irradiation because of its physical characteristics, and is deemed to be a feasible treatment modality...
  17. ncbi A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancer
    Junji Furuse
    Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
    Hepatogastroenterology 54:1575-8. 2007
    ..The purpose of this study was to determine the feasible dose of hypofractionated radiotherapy that could be followed by full-dose gemcitabine in patients with locally advanced pancreatic cancer...
  18. ncbi Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma
    Mitsuhiko Kawashima
    Division of Radiation Oncology, Hepatobiliary, and Pancreatic Medical Oncology, and Hepatobiliary Surgery, National Cancer Center Hospital East, Chiba, Japan
    J Clin Oncol 23:1839-46. 2005
    ..To evaluate the safety and efficacy of proton beam radiotherapy (PRT) for hepatocellular carcinoma...
  19. ncbi Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy
    Masami Ito
    Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    BMC Cancer 12:27. 2012
    ..The purpose of this study was to identify the risk factors associated with fatal pulmonary hemorrhage (PH) in patients with locally advanced non-small cell lung cancer (NSCLC), treated with chemoradiotherapy...
  20. ncbi Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival
    Mikiya Ishihara
    Divisions of Oncology Hematology, National Cancer Center Hospital East, Kashiwa, Japan mishihara clin medic mie u ac jp
    Oncology 84:135-40. 2013
    ..Identifying factors that predispose patients to central nervous system (CNS) metastases may hasten disease detection and improve treatment outcomes...
  21. ncbi Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus
    Satoshi Ishikura
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Japan
    Am J Clin Oncol 25:189-93. 2002
    ..Radiotherapy after TACE is feasible for patients with hepatocellular carcinoma and PVTT. The survival figure, however, is still dismal, and further investigation is needed to establish the best combination of treatment modalities...
  22. ncbi A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer
    Takako Eguchi Nakajima
    Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    Jpn J Clin Oncol 39:37-42. 2009
    ..This Phase I trial was designed to determine the maximal tolerated dose (MTD) and dose-limiting toxicity (DLT) of 5-FU on Days 1-4 and 29-32 with CDDP on Days 1 and 29 plus concurrent radiotherapy (50.4 Gy) among the Japanese...
  23. ncbi Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus Cisplatin followed by pemetrexed consolidation therapy in Japanese patients with locally advanced nonsquamous non-small-cell lung cancer
    Seiji Niho
    Division of Thoracic Oncology, National Cancer Centre Hospital East, Chiba, Japan
    Clin Lung Cancer 14:62-9. 2013
    ..We determined the recommended dose (RD) of thoracic radiotherapy (TRT) with a concurrent chemotherapy combination of pemetrexed and cisplatin in Japanese patients with nonsquamous non-small-cell lung cancer (NSCLC)...
  24. ncbi Initial experience with the quality assurance program of radiation therapy on behalf of Japan Radiation Oncology Group (JAROG)
    Koichi Isobe
    Department of Radiology, Chiba University Hospital, Chiba, Japan
    Jpn J Clin Oncol 37:135-9. 2007
    ..We evaluated the efficacy of our quality assurance (QA) program of radiation therapy (RT) in a prospective phase II study. This is the first description of the experience of the Japan Radiation Oncology Group (JAROG) with this program...
  25. ncbi External-beam radiotherapy for localized or locally advanced prostate cancer in Japan: a multi-institutional outcome analysis
    Katsumasa Nakamura
    Department of Radiology, School of Medicine, Fukuoka University, Nanakuma 7 45 1, Jonan ku, Fukuoka 814 0180, Japan
    Jpn J Clin Oncol 38:200-4. 2008
    ..The outcomes of patients with localized or locally advanced prostate cancer treated with external-beam radiotherapy are not well known in Japan...
  26. ncbi Randomized controlled trial to evaluate radiotherapy +/- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG 0401
    Akira Yokomizo
    Department of Urology, Graduate School of Medical Science, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan
    Jpn J Clin Oncol 35:34-6. 2005
    ..The Clinical Trial Review Committee of the JCOG approved the protocol on April 13, 2004, and the study was activated on May 17, 2004...